You are here

Coronary Intervention & Surgery

 

Cigarette smokers who were younger than 50 years old were more than eight times more likely to have an acute ST-segment elevation MI (STEMI) than non-smokers in their age category, according to an analysis of two studies in the United Kingdom.

A new metallic heart stent from Berlin, Germany-based Biotronik was proved effective in new research presented at VEITHsymposium 2016, a cardiology conference in New York.

A recent study shows that interactions among healthcare professionals may even help determine patients’ short-term outcomes following CABG.

Abbott Laboratories’ new Absorb bioresorbable heart stent has been approved in Japan to treat coronary artery disease, joining the U.S. and Canada in countries that have approved its use, according to a statement from Abbott.

New findings on Medtronic’s drug-filled stent (DFS) were unveiled this week at the annual Transcatheter Cardiovascular Therapeutics (TCT) 2016 conference that suggest metallic stents are still being improved and won’t be phased out anytime soon.

 

Recent Headlines

Smokers under 50 years old have 8-fold increased risk of acute STEMI

Cigarette smokers who were younger than 50 years old were more than eight times more likely to have an acute ST-segment elevation MI (STEMI) than non-smokers in their age category, according to an analysis of two studies in the United Kingdom.

Studies may underestimate permanent pacemaker implantations following TAVR

An analysis of 28 multicenter registries and nine randomized trials found that transcatheter aortic valve replacement (TAVR) studies tended to underestimate the incidence of permanent pacemaker implantations because they do not include patients who had permanent pacemakers before undergoing TAVR.

TAVR, TAVI market predicted to be worth $5.9 billion by 2022

Hefty growth is expected for the transcatheter aortic valve replacement and implantation (TAVR and TAVI) market, according to a new report that projects the market will be valued at $5.9 billion by 2022.

New self-expanding heart stent from Biotronik proves effective in clinical trial

A new metallic heart stent from Berlin, Germany-based Biotronik was proved effective in new research presented at VEITHsymposium 2016, a cardiology conference in New York.

What becomes of the broken hearted?

Extracellular matrices found in zebrafish were successfully transmitted into adult mouse hearts to help them regenerate heart tissue after acute MIs. 

Step up and walk for better heart health

Moderate-intensity walking can improve cardiovascular risk factors in the short term, according to new research from Binghamton University, State University of New York.

AHA 2016: Similar mortality rates for CABG patients receiving single or bilateral internal thoracic artery grafts

After five years of follow-up, patients undergoing CABG who received single internal thoracic artery grafts had similar rates of mortality and cardiovascular events compared with those who received bilateral internal thoracic artery grafts, according to an interim analysis of an ongoing randomized trial.

AHA 2016: Study shows similar outcomes with tirofiban or bivalirudin during PCIs

Patients had similar rates of 30-day bleeding and 1-year death, MI or urgent target vessel revascularization whether they received anticoagulation with tirofiban or bivalirudin during PCIs, according to an observational study.

Robots to the rescue: First case of robotic PVI for below-the-knee intervention

According to a new report, robotic peripheral vascular intervention (PVI) can be safely and successfully performed for below-the-knee interventions.

The value of teamwork before, during and after CABG procedures

A recent study shows that interactions among healthcare professionals may even help determine patients’ short-term outcomes following CABG.

Pages